Please Note: This trial is no longer enrolling new participants
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Protocol No. | CTO-EAA173 | Scope | National |
---|---|---|---|
Principal Investigator | Rafat Abonour | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase III |